Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Laryngoscope Investigative Otolaryngology|April 23, 2025
Abnormalities of the Facial Nerve in Temporal Bones With Inner Ear MalformationsTomotaka Shimura, Jameel Alp, Nevra Keskin Yilmaz, et al.
Medicine|January 3, 2023
Differentiation between IgG4-related Mikulicz disease and Sjögren's syndrome: A review case report and literature reviewYurie Otani, Tomotaka Shimura, Taketoshi Nogaki, et al.
Oncotarget|November 29, 2016
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in JapanDaisuke Kawakita, Yuichiro Tada, Yorihisa Imanishi, et al.
Oncotarget|September 24, 2017
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classificationSoichiro Takase, Satoshi Kano, Yuichiro Tada, et al.
Virchows Archiv : an International Journal of Pathology|July 18, 2023
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinomaHideaki Hirai, Masato Nakaguro, Yuichiro Tada, et al.
Histopathology|July 12, 2018
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 casesMakoto Urano, Hideaki Hirai, Yuichiro Tada, et al.
The American Journal of Surgical Pathology|November 26, 2019
Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification ModelMasato Nakaguro, Yukiko Sato, Yuichiro Tada, et al.
Oncotarget|February 9, 2018
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomasTomotaka Shimura, Yuichiro Tada, Hideaki Hirai, et al.
Virchows Archiv : an International Journal of Pathology|February 28, 2020
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinomaHideaki Hirai, Yuichiro Tada, Masato Nakaguro, et al.
Frontiers in Oncology|February 21, 2022
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted TherapyNatsuki Saigusa, Hideaki Hirai, Yuichiro Tada, et al.
Pageof 3